推薦產品
產品名稱
Ascentis® Express Peptide ES C18 保护柱芯, 2.7 μm particle size, L × I.D. 5 mm × 2.1 mm, pkg of 3 ea
材料
stainless steel column
品質等級
agency
suitable for USP L1
產品線
Ascentis®
特點
endcapped: no
包裝
pkg of 3 ea
標籤範圍
4.6% carbon loading
技術
HPLC: suitable
LC/MS: suitable
UHPLC-MS: suitable
UHPLC: suitable
長度 × 內徑
5 mm × 2.1 mm
表面積
90 m2/g
基質
superficially porous particle
基質活性組
C18 (octadecyl) phase
粒徑
2.7 μm
孔徑
160 Å
工作pH值
1-9
分離技術
reversed phase
尋找類似的產品? 前往 產品比較指南
一般說明
Ascentis Express Guard Columns provide physical (filtration) and chemical protection for costly analytical columns without compromising the very high performance of Ascentis Express columns. These Ascentis Express guard columns are capable of continuous use at pressures up to 9000 psi (600 bar) with only hand-tightening. Guard cartridges are easily replaced without removing the guard column holder from the flow path. The cartridges are packed with Ascentis Express Fused-Core®particles. Order guard column holder (53500-U) separately.
法律資訊
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
Fused-Core is a registered trademark of Advanced Materials Technology, Inc.
未找到適合的產品?
試用我們的產品選擇工具.
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Journal of separation science, 38(8), 1351-1357 (2015-01-30)
The pentapeptide thymopentin (Arg-Lys-Asp-Val-Tyr, RKDVY) corresponds to amino acids 32-36 of the 49 amino acid immunomodulatory polypeptide, thymopoietin, whose biological activity is partially reproduced. Thymopentin is widely used in the clinic and represents a promising target for drug design but
Journal of chromatography. A, 1266, 34-42 (2012-11-03)
The recent introduction of new stationary phases for liquid chromatography based on superficially porous particles, called core-shell or fused-core, dramatically improved the separation performances through very high efficiency, due mainly to reduced eddy diffusion. However, few studies have evaluated the
Journal of pharmaceutical and biomedical analysis, 100, 393-401 (2014-09-15)
Cytochrome P450 (CYP) enzymes and UDP-glucuronosyltransferases (UGT) are major determinants in the pharmacokinetics of most drugs on the market. To investigate their impact on intestinal and hepatic drug metabolism, we developed and validated quantification methods for nine CYP (CYP1A2, CYP2B6
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務